Bora CDMO Bora CDMO

X
[{"orgOrder":0,"company":"Sanofi","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Sanofi and Merck's first and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"FRANCE","productType":"Vaccine","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals for Tetanus Vaccine

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Vaxelis is given to children from 6 weeks through 4 years of age (up to the 5th birthday) and is given as 3 shots, one at 2 months, one at 4 months and one at 6 months of age.

            Lead Product(s): DTwP Hib,Pertussis Vaccine,Tetanus Vaccine

            Therapeutic Area: Infections and Infectious Diseases Product Name: Vaxelis

            Highest Development Status: Approved Product Type: Vaccine

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable June 01, 2021

            Sanofi Company Banner

            Supplier's day 2024

            Not Confirmed

            envelop Contact Supplier
            Post Enquiry
            POST ENQUIRY